Web6. mar 2024 · At RedHill Biopharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. WebRedHill Biopharma is focused primarily on the acquisition and development of late clinical-stage formulations of existing drugs. Search Crunchbase. Start Free Trial . ... 172 Number of Organizations • $12.2B Total Funding Amount • 426 Number of Investors. Track . Pharmaceutical Companies With Less Than $1B in Revenue (Top 10K)
RedHill Biopharma (NASDAQ / TASE: RDHL) Aktienforum Aktien …
Web9. sep 2024 · RedHill Biopharma - Investors - Events & Presentations Events & Presentations Upcoming Events January 7, 2013 The 31st Annual J.P. Morgan Healthcare Conference Add to Calendar March 11, 2013 BioEurope Conference Add to Calendar March 19, 2013 10:30 AM PDT 25th Annual ROTH Conference Dror Ben-Asher, CEO Add to Calendar April 22, 2013 Web12. dec 2024 · About SEC Filings. Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange … club der hanseaten
Redhill Biopharma Inc. Company Profile Raleigh, NC
Web11. apr 2024 · RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma Ltd. Country: Israel: Founded: 2009: ... Senior Business Development and Investor Relations Manager: Kristin Comer: Vice President, General Counsel and Chief Compliance Officer: Valerie Graceffa: Vice President of Sales: Web6. okt 2024 · Company contact: Adi Frish Senior VP Business Development & Licensing RedHill Biopharma +972-54-6543-112 [email protected]. IR contact (U.S.): Timothy McCarthy, CFA, MBA Web26. aug 2024 · RedHill Biopharma Ltd. ( NASDAQ: RDHL) Q2 2024 Earnings Conference Call August 26, 2024 8:30 AM ET Company Participants Alexandra Okmian - Senior Business Development and Investor Relations... club der selfpublisher